Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Adenosine A1 receptor agonists as clinically viable agents for treatment of ischemic brain disorders.

× No keyword cloud information.

25 in total

1. Direct autoradiographic localization of adenosine A2 receptors in the rat brain using the A2-selective agonist, [3H]CGS 21680.

Authors: M F Jarvis; M Williams
Journal: Eur J Pharmacol Date: 1989-09-13 Impact factor: 4.432

2. Purinergic depression of neurons in different areas of the rat brain.

Authors: G K Kostopoulos; J W Phillis
Journal: Exp Neurol Date: 1977-06 Impact factor: 5.330

3. Endogenously released adenosine regulates excitability in the in vitro hippocampus.

Authors: T V Dunwiddie
Journal: Epilepsia Date: 1980-10 Impact factor: 5.864

4. N-substituted adenosines as novel neuroprotective A(1) agonists with diminished hypotensive effects.

Authors: L J Knutsen; J Lau; H Petersen; C Thomsen; J U Weis; M Shalmi; M E Judge; A J Hansen; M J Sheardown
Journal: J Med Chem Date: 1999-09-09 Impact factor: 7.446

5. Chronic administration of selective adenosine A1 receptor agonist or antagonist in cerebral ischemia.

Authors: D K Von Lubitz; R C Lin; N Melman; X D Ji; M F Carter; K A Jacobson
Journal: Eur J Pharmacol Date: 1994-04-21 Impact factor: 4.432

Review 6. Adenosine and brain ischemia.

Authors: K A Rudolphi; P Schubert; F E Parkinson; B B Fredholm
Journal: Cerebrovasc Brain Metab Rev Date: 1992

Review 7. Neuroprotective role of adenosine in cerebral ischaemia.

Authors: K A Rudolphi; P Schubert; F E Parkinson; B B Fredholm
Journal: Trends Pharmacol Sci Date: 1992-12 Impact factor: 14.819

Review 8. Adenosine A1 and A2 receptors: structure--function relationships.

Authors: P J van Galen; G L Stiles; G Michaels; K A Jacobson
Journal: Med Res Rev Date: 1992-09 Impact factor: 12.944

Review 9. Adenosine: a prototherapeutic concept in neurodegeneration.

Authors: D K von Lubitz; M F Carter; M Beenhakker; R C Lin; K A Jacobson
Journal: Ann N Y Acad Sci Date: 1995-09-15 Impact factor: 5.691

10. Chronic adenosine A1 receptor agonist and antagonist: effect on receptor density and N-methyl-D-aspartate induced seizures in mice.

Authors: D K Von Lubitz; I A Paul; X D Ji; M Carter; K A Jacobson
Journal: Eur J Pharmacol Date: 1994-02-21 Impact factor: 4.432

9 in total

1. Translating drug-induced hibernation to therapeutic hypothermia.

Authors: Tulasi R Jinka; Velva M Combs; Kelly L Drew
Journal: ACS Chem Neurosci Date: 2015-04-08 Impact factor: 4.418

2. Direct measurement of adenosine release during hypoxia in the CA1 region of the rat hippocampal slice.

Authors: N Dale; T Pearson; B G Frenguelli
Journal: J Physiol Date: 2000-07-01 Impact factor: 5.182

3. The adenosine A1 receptor agonist adenosine amine congener exerts a neuroprotective effect against the development of striatal lesions and motor impairments in the 3-nitropropionic acid model of neurotoxicity.

Authors: David Blum; David Gall; Marie-Christine Galas; Pablo d'Alcantara; Kadiombo Bantubungi; Serge N Schiffmann
Journal: J Neurosci Date: 2002-10-15 Impact factor: 6.167

Adenosine A1 receptor agonists as clinically viable agents for treatment of ischemic brain disorders.

1. Direct autoradiographic localization of adenosine A2 receptors in the rat brain using the A2-selective agonist, [3H]CGS 21680.

2. Purinergic depression of neurons in different areas of the rat brain.

3. Endogenously released adenosine regulates excitability in the in vitro hippocampus.

4. N-substituted adenosines as novel neuroprotective A(1) agonists with diminished hypotensive effects.

5. Chronic administration of selective adenosine A1 receptor agonist or antagonist in cerebral ischemia.

Review 6. Adenosine and brain ischemia.

Review 7. Neuroprotective role of adenosine in cerebral ischaemia.

Review 8. Adenosine A1 and A2 receptors: structure--function relationships.

Review 9. Adenosine: a prototherapeutic concept in neurodegeneration.

10. Chronic adenosine A1 receptor agonist and antagonist: effect on receptor density and N-methyl-D-aspartate induced seizures in mice.

1. Translating drug-induced hibernation to therapeutic hypothermia.

2. Direct measurement of adenosine release during hypoxia in the CA1 region of the rat hippocampal slice.

3. The adenosine A1 receptor agonist adenosine amine congener exerts a neuroprotective effect against the development of striatal lesions and motor impairments in the 3-nitropropionic acid model of neurotoxicity.

4. Altered thermoregulation via sensitization of A1 adenosine receptors in dietary-restricted rats.

5. Seizure activity produces differential changes in adenosine A1 receptors within rat hippocampus.

Review 6. Hypothalamic or Extrahypothalamic Modulation and Targeted Temperature Management After Brain Injury.

7. NMDA receptor-mediated extracellular adenosine accumulation is blocked by phosphatase 1/2A inhibitors.

8. Protection against ischemic damage by adenosine amine congener, a potent and selective adenosine A1 receptor agonist.

9. Neuroprotection by adenosine in the brain: From A(1) receptor activation to A (2A) receptor blockade.